Comparison 10. Fractional carbon dioxide (CO₂) laser versus Intralesional Verapamil.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
10.1 Incidence of treatment‐related adverse effects (24 weeks)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
10.1.1 Charring (24 weeks)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
10.1.2 Pain at injection site (24 weeks)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
10.2 Scar size, colour, height, length, width and pliability, skin surface texture, pruritus and pain (12 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.2.1 Height	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.2.2 Pigmentation	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.2.3 Vascularity	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.2.4 Pliability	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.3 Scar size, colour, height, length, width and pliability, skin surface texture, pruritus and pain (24 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.3.1 Height	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.3.2 Pigmentation	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
10.3.3 Vascularity	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected